Medarex, Celgene soar; Celera tanks
July 23, 2009 at 12:57 PM EDT
Drug stocks gain ground as shares of Medarex Inc. rocketed on news that it was being bought by Bristol-Myers Squibb for $2.1 billion.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.